Cure Leukaemia
At a glance
Key takeaways
- Your work is most likely to fit if it concerns blood cancer clinical trials, stem-cell transplant research or paediatric transplant trials, which are the funder's stated themes.
- No grant range is published, so the annual report is the best place to check what sizes of award have been made before you set an amount.
- No application process is published, so start by contacting the charity through the contact it shows, and note that potential grants are reviewed case by case, depending on available resources.
- The sources give no deadlines and say nothing about how competitive the funder is or whether relationships matter, so ask about timing when you make contact.
Overview
Cure Leukaemia is a charity registered with the Charity Commission for England and Wales (charity number 1100154).
Cure Leukaemia exists to fund new therapies and treatments for leukaemia patients across the United Kingdom. It was established to allow patients with blood cancer to access remarkably effective new treatments which were then becoming available. It awards £832,278 annually, funding research nurses and clinical roles at blood cancer centres across the UK. Its programmes are the Trials Acceleration Programme, which links the UK's leading blood cancer centres through specialist research nurses, the IMPACT network, which focuses on improving outcomes for patients undergoing stem-cell (bone marrow) transplants, and the ATICUS Network, which is dedicated to paediatric stem-cell transplant trials.
What they fund
Priority Areas
Cure Leukaemia funds research nurses and clinical roles at blood cancer centres across the UK, giving adults and children access to innovative treatments through clinical trials. Its work supports national networks of leading blood cancer and transplant centres, and clinical research intended to improve treatment access, outcomes and care. The Trials Acceleration Programme links leading centres through specialist research nurses so that adults with blood cancers including leukaemia, lymphoma and myeloma can access clinical trials wherever they live in the UK. The IMPACT network brings transplant centres and partner hospitals together to run national clinical trials, while the ATICUS Network is dedicated to paediatric stem-cell transplant trials. Potential grant recipients are reviewed case by case according to available resources.
Themes
- Blood cancer clinical trials
- Stem-cell transplant research
- Paediatric transplant trials
Geographic Focus
The UK.
How to apply
No application process is published in the charity's annual report, its register entry or its website. The contact shown is for getting in touch.
Application success factors
What the charity says:
- Potential grant recipients are reviewed case by case, depending on available resources.
Where they fund
Where it says it funds
- United Kingdom
Similar funders
Funders supporting work similar to Cure Leukaemia.
Five years of accounts
| Financial year | Income | Expenditure | Grants paid | Accounts document |
|---|---|---|---|---|
| year to 31 October 2021 | £2,279,754 | £2,295,212 | £652,957 | Accounts for year to 31 October 2021 |
| year to 31 October 2022 | £2,677,058 | £2,347,971 | £478,827 | Accounts for year to 31 October 2022 |
| year to 31 October 2023 | £2,879,253 | £3,020,683 | £786,777 | Accounts for year to 31 October 2023 |
| year to 31 October 2024 | £2,918,464 | £2,906,092 | £302,796 | Accounts for year to 31 October 2024 |
| year to 31 October 2025 | £3,709,158 | £3,617,294 | £832,278 | Accounts for year to 31 October 2025 |
Income vs grants paid
IncomeGrants paid
Total value each financial year
Grants paid stayed within income across the 5 years shown.
- Grants paid, year to 31 October 2021; year to 31 October 2022; year to 31 October 2023; year to 31 October 2024: grants to institutions, as reported on the charity register (Part B).
- Grants paid, year to 31 October 2025: grants awarded in the year, as reported in the accounts.
Figures from the charity’s filed accounts and its register entry. The document icon links to the charity’s entry on the Charity Commission register, where its filed accounts can be found.
Sources
Registers and filings
Other sources
- cureleukaemia.co.uk
- cureleukaemia.co.uk/about · read on 30 October 2026
- cureleukaemia.co.uk/patient-hub/trials-acceleration-programme · read on 30 October 2026
- cureleukaemia.co.uk/patient-hub/impact-network · read on 30 October 2026
- cureleukaemia.co.uk/patient-hub/the-aticus-network · read on 30 October 2026
- cureleukaemia.co.uk/contact-us · read on 30 October 2026
- Annual report (year to 31 October 2025)
This profile draws on the funder’s own website as well as its filed accounts.
Sources last checked on 30 October 2026.
🎯 You've done the research. Now write an application they can't refuse.
Hinchilla combines funder's specific priorities with your organisation's past successful grants and AI analysis of what reviewers want to see.
Data privacy and security by default
Your organisation's past successful grants and experience
AI analysis of what reviewers want to see
A compelling draft application in 10 minutes instead of 10 hours
Spotted something that needs correcting? Let us know
At a glance
Applying to Cure Leukaemia?
Hinchilla drafts your answers around this funder's priorities, using your organisation's own documents.
No credit card required
Contact
- info@cureleukaemia.co.uksource
- Cure Leukaemia, PO Box 18280, Solihull, B90 9NAsource
- cureleukaemia.co.uk
- Contact form
Applying to Cure Leukaemia?
Hinchilla drafts your answers around this funder's priorities, using your organisation's own documents.
No credit card required
Contact
- info@cureleukaemia.co.uksource
- Cure Leukaemia, PO Box 18280, Solihull, B90 9NAsource
- cureleukaemia.co.uk
- Contact form